Showing results (181-190 of 195) with videos related to
Sort By:
Pageof 20
Theranostics|April 25, 2017
Dual Somatostatin Receptor/FDG PET/CT Imaging in Metastatic Neuroendocrine Tumours: Proposal for a Novel Grading Scheme with Prognostic SignificanceDavid Lh Chan, Nick Pavlakis, Geoffrey P Schembri, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 2, 2024
[18F]FDG PET/CT-Avid Discordant Volume as a Biomarker in Patients with Gastroenteropancreatic Neuroendocrine Neoplasms: A Multicenter StudyDavid L Chan, Aimee R Hayes, Ioannis Karfis, et al.Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|December 17, 2010
Controversies in diagnosis of pulmonary embolismPaul D Stein, H Dirk Sostman, James E Dalen, et al.The Lancet. Oncology|September 6, 2017
Safety and activity of microRNA-loaded minicells in patients with recurrent malignant pleural mesothelioma: a first-in-man, phase 1, open-label, dose-escalation studyNico van Zandwijk, Nick Pavlakis, Steven C Kao, et al.Asia Oceania Journal of Nuclear Medicine & Biology|July 12, 2021
Safety and tolerability of Miltuximab® - a first in human study in patients with advanced solid cancersDhanusha Sabanathan, Douglas H Campbell, Vicki M Velonas, et al.JAMA Oncology|October 3, 2024
Biomarkers to Inform Prognosis and Treatment for Unresectable or Metastatic GEP-NENsJonathan M Loree, David Chan, Jennifer Lim, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 2, 2009
SPECT in acute pulmonary embolismPaul D Stein, Leonard M Freeman, H Dirk Sostman, et al.British Journal of Cancer|November 26, 2022
Dual [68Ga]DOTATATE and [18F]FDG PET/CT in patients with metastatic gastroenteropancreatic neuroendocrine neoplasms: a multicentre validation of the NETPET scoreDavid L Chan, Aimee R Hayes, Ioannis Karfis, et al.JAMA Oncology|July 29, 2018
Follow-up Recommendations for Completely Resected Gastroenteropancreatic Neuroendocrine TumorsSimron Singh, Lesley Moody, David L Chan, et al.European Journal of Cancer (Oxford, England : 1990)|May 16, 2026
[177Lu]Lu-DOTATATE PRRT and CAPTEM chemotherapy for pancreas and small bowel neuroendocrine tumours: The AGITG CONTROL NETS Multi-centre randomized trialDavid L Chan, Katrin Marie Sjoquist, David Turner Ransom, et al.Pageof 20